Bone mineral density increases with vitamin D repletion in patients with coexistent vitamin D insufficiency and primary hyperparathyroidism

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 10, 2000, Pages 3541-3543

  Kantorovich, Vitaly ^a   Gacad, Mercedes A ^a   Seeger, Leanne L ^a   Adams, John S ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BURNS AND ALLEN RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERGOCALCIFEROL; PARATHYROID HORMONE; VITAMIN D;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE MINERAL; CLINICAL ARTICLE; COMORBIDITY; FEMALE; HIP; HUMAN; MALE; PARATHYROID HORMONE BLOOD LEVEL; PREVALENCE; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; REBOUND; SPINE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

EID: 0033766588     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.85.10.3541     Document Type: Article

References (15)

1. Prevalence of low femoral bone density in older U.S. adults from NHANES III
2. The osteoporosis revolution
3. Increased bone mineral density following parathyroidectomy in primary hyperparathyroidism
4. Resolution of vitamin D insufficiency in osteopenic patients results in rapid recovery of bone mineral density
5. Primary hyperparathyroidism. Incidence, morbidity, and potential economic impact in a community
6. Hypovitaminosis D in an Italian population of healthy subjects and hospitalized patients
7. Vitamin D deficiency in homebound elderly persons
8. Acquired vitamin D deficiency and hyperparathyroidism
9. Is the clinical expression of primary hyperparathyroidism a function of the long-term vitamin D status of the patient?
10. Parathyroid function in human vitamin D deficiency and vitamin D deficiency in primary hyperparathyroidism
11. The effects of vitamin D insufficiency in patients with primary hyperparathyroidism
12. Markers of bone remodeling in the elderly subject: Effects of vitamin D insufficiency and its correction
13. Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women
14. Skeletal disease in primary hyperparathyroidism
15. Antifracture efficacy of antiresorptive agents are related to changes in bone density